Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: Lancet Diabetes Endocrinol. 2019 Apr 26;7(6):452–461. doi: 10.1016/S2213-8587(19)30093-2

Table 1:

Characteristics of the control and combined intervention groups at baseline (1986) and at 30-year follow-up (2016)

Control group
(n=138)
Intervention group
(n=438)
Baseline (1986)

Age (years) 46.6 (9.3) 44.7 (9.3)
Sex
 Men 79 (57%) 233 (53%)
 Women 59 (43%) 205 (47%)
BMI (kg/m2) 26.2 (3.8) 25.6 (4.0)
Systolic blood pressure (mm Hg) 133.4 (26.0) 131.9 (24.3)
Diastolic blood pressure (mm Hg) 87.8 (15.4) 87.0 (14.1)
Total cholesterol (mmol/L) 5.2 (1.1) 5.0 (1.4)
Fasting plasma glucose (mmol/L) 5.5 (0.8) 5.6 (0.8)
2-h plasma glucose (mmol/L) 9.0 (0.9) 9.0 (0.9)
Current smoker 69 (50%) 169 (39%)

30-year follow-up (2016)

Participants lost to follow-up 3 (2%) 33 (8%)
Participants dead 76 (55%) 185 (42%)
Participants alive 59 (43%) 220 (50%)
Age (years) 71.8 (6.9) 70.5 (6.6)
Sex
 Male 25 (42%) 86 (39%)
 Female 34 (58%) 134 (61%)
Participants examined 48 (81%) 183 (83%)
BMI (kg/m2) 24.7 (3.9) 24.5 (3.3)
Change in BMI from 1986 to 2016 (kg/m2) −1.1 (3.4) 1.2 (3.3)
Systolic blood pressure (mm Hg) 143.9 (19.3) 148.1 (21.2)
Diastolic blood pressure (mm Hg) 74.2 (7.4) 77.6 (10.4)
Total cholesterol (mmol/L) 4.9 (0.9) 5.0 (1.4)
Fasting plasma glucose (mmol/L) 7.8 (2.8) 7.4 (2.9)
2-h plasma glucose (mmol/L) 11.8 (3.5) 10.1 (3.5)
HbA1c (mmol/mol) 61.6 (17.6) 60.9 (18.3)
HbA1c (%) 7.8 (1.6) 7.7 (1.7)

Data are n (%) or mean (SD).